RSS feeds allow Web site content to be gathered via feed reader software. Click the subscribe link to obtain the feed URL for this page. The feed will update when new content appears on this page.

Bristol Myers Squibb Company

A collection of news and information related to Bristol Myers Squibb Company published by this site and its partners.

Top Bristol Myers Squibb Company Articles see all

Displaying items 1-5
  • Former York High teacher wants melanoma awareness

    Former York High teacher wants melanoma awareness
    Prayer, positive thinking and participation in a clinical trial using a drug as-yet unapproved by the U.S. Food and Drug Administration have got her to this point.
  • Bristol-Myers recalls 6 lots of blood thinner injection

    Bristol-Myers recalls 6 lots of blood thinner injection
    Bristol-Myers said July 1 it is recalling six lots of blood thinner injectionJuly 1 (Reuters) - Bristol-Myers Squibb Co said it was voluntarily recalling six lots of the injectable version of its blood thinner, Coumadin, in the United States, after...

    Drug prices: Costly cures

    Drug prices: Costly cures
    Drug company executives, investment analysts, doctors and academics swarmed into Chicago between May 30th and June 3rd for the year's biggest meeting on cancer. Treatments for cancer account for more than 30% of pharmaceutical firms' early-stage...

    Exclusive: U.S. approval of Merck cancer immunotherapy expected soon

    Exclusive: U.S. approval of Merck cancer immunotherapy expected soon
    U.S. regulators are likely to approve Merck & Co's highly anticipated immuno-oncology drug, pembrolizumab, as a treatment for melanoma well ahead of a late October deadline, according to three sources familiar with the situation. If approved by the...

    FDA approves new diabetes medication

    FDA approves new diabetes medication
    The Food and Drug Administration on Wednesday approved U.S. marketing of the drug dapagliflozin, the second of a new class of medications that aim to improve glycemic control in patients with Type 2 diabetes. The drug will be marketed under the name...